- Clinical Trials
Note: When you click on media articles below, a new page will open indicating that you are leaving the Genprex, Inc. website and entering a third-party website not affiliated with Genprex Inc. or any of its affiliates. No information contained in a linked site has been endorsed or approved by Genprex, Inc. and Genprex, Inc. is not responsible for the content of such third-party websites.
How gene therapy is reprogramming the course of lung cancer.
Lead product, Oncoprex, is an injectable treatment for lung cancer.
SPORE Grants Turn Into Hope for Patients.